ClassID:

20391

A61K31/4704 - page 3 - CPC Classification

Classification description:

Medicinal preparations containing organic active ingredients; Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom; Quinolines; Isoquinolines 2-Quinolinones, e.g. carbostyril

Recent Application in this class:
#601
20070225329
2007-09-27

Aryl aniline βadrenergic receptor agonists

#602
20070219243
2007-09-20

Method for improving the pharmacokinetics of HIV integrase inhibitors

#603
20070202053
2007-08-30

Pharmaceutical formulations for dry powder inhalers comprising a low-dosage strength active ingredient

#604
20070191291
2007-08-16

Compound antibacterial drugs comprising n-acetyl-d-glucosamine

#605
20070190070
2007-08-16

Methods of using and compositions comprising selective cytokine inhibitory drugs for the treatment and management of disorders of the central nervous system

#606
20070161608
2007-07-12

Selective androgen receptor modulators for treating muscle wasting

#607
20070149451
2007-06-28

Combination of a dpp IV inhibitor and an antiobesity or appetite regulating agent

#608
20070123521
2007-05-31

Cinnamoyl derivatives and use thereof

#609
20070117840
2007-05-24

Receptor antagonist

#610
20070112026
2007-05-17

Carbostyril derivatives for accelerating salivation

#611
20070093471
2007-04-26

Compositions and methods for the administration clozapine formulations which modulate body weight

#612
20070088050
2007-04-19

Crystals of laquinimod sodium, and process for the manufacture thereof

#613
20070066568
2007-03-22

Treating renal disease, burns, wounds and spinal cord injury with selective androgen receptor modulators

#614
20070065366
2007-03-22

Pharmaceutical formulations comprising a long-acting beta2-agonist for administration by nebulisation

#615
20070060608
2007-03-15

Combination products with carboxylic acid derivatives that inhibit the binding of integrins to their receptors and other therapeutic compounds

#616
20070032427
2007-02-08

Methods and compositions for preserving the viability of photoreceptor cells

#617
20070031513
2007-02-08

Carbostyril derivatives and mood stabilizers for treating mood disorders

#618
20070025920
2007-02-01

Stable Pharmaceutical Solution Formulations for Pressurized Metered Dose Inhalers

#619
20070015786
2007-01-18

Treatment of hot flashes, impulse control disorders and personality change due to a general medical condition

#620
20070015727
2007-01-18

Delivery of modulators of glutamate-mediated neurotransmission to the inner ear

#621
20070010552
2007-01-11

Fluorinated heterocyclic compounds and methods of synthesis

#622
20060287238
2006-12-21

Combinations of DnaK inhibitors with known antibacterial agents

#623
20060276477
2006-12-07

Treatment method for anemia

#624
20060270612
2006-11-30

Method of modulating stress-activated protein kinase system

#625
20060258673
2006-11-16

Process of making crystalline Type II aripiprazole

#626
20060257471
2006-11-16

Pharmaceutical tablets of crystalline type II aripiprazole

#627
20060257324
2006-11-16

Pharmaceutical solution formulations for pressurised metered dose inhalers

#628
20060241188
2006-10-26

Treatment of pervasive developemental disorders with norepinephrine reuptake inhibitors

#629
20060241059
2006-10-26

Treatments for viral infections

#630
20060239935
2006-10-26

COMPOSITIONS FOR INHALATION

#631
20060235045
2006-10-19

Therapeutic agent for chronic obstructive pulmonary disease and method for treatment for chronic obstructive pulmonary disease with the same

#632
20060199868
2006-09-07

Use of beta-adrenoceptor antagonists for the manufacture of a medicament for the treatment of disorders of the outer retina

#633
20060193785
2006-08-31

Pharmaceutical aerosol formulations for pressurized metered dose inhalers comprising a sequestering agent

#634
20060188471
2006-08-24

METHODS OF TREATING EPITHELIAL LESIONS

#635
20060142279
2006-06-29

Treatment of latent tuberculosis

#636
20060120966
2006-06-08

Salmeterol superfine formulation

#637
20060052352
2006-03-09

Mixtures or organic compounds for the treatment of airway diseases

#638
20060019931
2006-01-26

Treating bone-related disorders with selective androgen receptor modulators

#639
20060009488
2006-01-12

Prodrugs of selective androgen receptor modulators and methods of use thereof

#640
20050220718
2005-10-06

Stable pharmaceutical solution formulations for pressurized metered dose inhalers

#641
20050165053
2005-07-28

Substituted4-aryl-3-(3-aryl-1-oxo-2-propenyl)-2(1h)-quinolinones and analogs as activators of caspases and inducers of apoptosis and the use thereof

#642
20050154013
2005-07-14

Pressurised metered dose inhalers containing solutions of beta-2 agonists

#643
20050152846
2005-07-14

Formoterol superfine formulation

#644
20050129621
2005-06-16

Aerosol formulations for pulmonary administration of medicaments to produce a systemic effect

#645
20050101590
2005-05-12

Antipruritics

#646
20050100530
2005-05-12

Medicinal composition

#647
20050095290
2005-05-05

Medicinal composition

#648
20050032833
2005-02-10

Fluorinated heterocyclic compounds and methods of synthesis

#649
20050025718
2005-02-03

Medicaments for inhalation comprising an anticholinergic and a betamimetic

#650
20050009795
2005-01-13

Mixtures or organic compounds for the treatment of airway diseases

#651
14239722
2016-01-26

Method for preparing metered dose sprayed inhaler for treating respiratory disease